Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or α-blockers

Drug Safety

Volumn 31, Issue 3, 2008, Pages 241-247

  French, Dustin D ^a,b   Margo, Curtis E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Alpha adrenergic receptor antagonists, drug interactions; Drug interactions; Optic nerve disorders, drug induced; Organic nitrates, drug interactions; Phosphodiesterase V inhibitors, drug interactions

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ORGANIC NITRATE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG SAFETY; HUMAN; INCIDENTAL FINDING; ISCHEMIC OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; VETERAN;

EID: 39749158447     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831030-00005     Document Type: Article

References (26)

1. 1. AV Cunningham KH Smith 2001 Anterior ischemic optic neuropathy associated with viagra J Neuroophthalmol 21 22 5 11315976 10.1097/00041327-200103000-00006 1:STN:280:DC%2BD3MvgvFejtg%3D%3D Cunningham AV, Smith KH. Anterior ischemic optic neuropathy associated with viagra. J Neuroophthalmol 2001; 21: 22–5
2. 2. R Egan H Pomeranz 2000 Sildenafil (Viagra) associated anterior ischemic optic neuropathy Arch Ophthalmol 118 291 2 10676804 1:STN:280:DC%2BD3c7jvF2ktg%3D%3D Egan R, Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000; 118: 291–2
3. 3. HD Pomeranz KH Smith WM Hart Jr 2002 Sildenafil-associated nonarteritic anterior ischemic optic neuropathy Ophthalmology 109 584 7 11874765 10.1016/S0161-6420(01)00976-9 Pomeranz HD, Smith KH, Hart Jr WM, et al. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109: 584–7
4. 4. S Dheer GS Rekhi S Merlyn 2002 Sildenafil associated anterior ischemic optic neuropathy [letter J Assoc Physicians India 50 265 12038660 Dheer S, Rekhi GS, Merlyn S. Sildenafil associated anterior ischemic optic neuropathy [letter]. J Assoc Physicians India 2002; 50: 265
5. 5. A Boshier N Pambakian SA Shakir 2002 A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil Int J Clin Pharmacol Ther 40 422 3 12358159 1:STN:280:DC%2BD38vps1KisQ%3D%3D Boshier A, Pambakian N, Shakir SA. A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil. Int J Clin Pharmacol Ther 2002; 40: 422–3
6. 6. JS Gandhi 2003 Sildenafil-associated NAION Ophthalmology 110 1860 1 13129901 10.1016/S0161-6420(03)00847-9 Gandhi JS. Sildenafil-associated NAION. Ophthalmology 2003; 110: 1860–1
7. 7. N Gruhn HC Fledelius 2005 Unilateral optic neuropathy associated with sildenafil intake Acta Ophthalmol Scan 83 131 2 10.1111/j.1600-0420.2005.00374.x Gruhn N, Fledelius HC. Unilateral optic neuropathy associated with sildenafil intake. Acta Ophthalmol Scan 2005; 83: 131–2
8. 8. HD Pomeranz AR Bhavsar 2005 Nonarteritic ischemic optic neuro-pathy developing soon after use of sildenafil (Viagra): a report of seven new cases J Neuroophthalmol 25 9 13 15756125 10.1097/00041327-200503000-00003 Pomeranz HD, Bhavsar AR. Nonarteritic ischemic optic neuro-pathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 2005; 25: 9–13
9. 9. RA Egan FW Fraunfelder 2005 Viagra and anterior ischemic optic neuropathy Arch Ophthalmol 123 709 10 15883302 10.1001/archopht.123.5.709-b Egan RA, Fraunfelder FW. Viagra and anterior ischemic optic neuropathy. Arch Ophthalmol 2005; 123: 709–10
10. 10. CE Margo DD French 2007 Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors Am J Ophthalmol 143 538 9 17317413 10.1016/j.ajo.2006.10.006 1:CAS:528:DC%2BD2sXitFOkt7w%3D Margo CE, French DD. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol 2007; 143: 538–9
11. 11. FW Fraunfelder 2005 Visual side effects associated with erectile dysfunction agents Am J Ophthalmol 140 723 4 16226525 10.1016/j.ajo.2005.02.049 1:CAS:528:DC%2BD2MXhtFSmt7%2FF Fraunfelder FW. Visual side effects associated with erectile dysfunction agents. Am J Ophthalmol 2005; 140: 723–4
12. 12. FW Fraunfelder HD Pomeranz RA Egan 2006 Nonarteritic anterior ischemic optic neuropathy and sildenafil Arch Ophthalmol 124 733 4 16682597 10.1001/archopht.124.5.733 Fraunfelder FW, Pomeranz HD, Egan RA. Nonarteritic anterior ischemic optic neuropathy and sildenafil. Arch Ophthalmol 2006; 124: 733–4
13. 13. JF Rizzo III S Lesseil 1991 Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles Arch Ophthalmol 109 1668 72 1841572 10.1001/archopht.1991.01080120052024 Rizzo III JF, Lesseil S. Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles. Arch Ophthalmol 1991; 109: 1668–72
14. 14. MX Repka PJ Savino NJ Schatz 1983 Clinical profile and long-term implications of anterior ischemic optic neuropathy Am J Ophthalmol 96 478 83 6624829 1:STN:280:DyaL2c%2FitFWqsw%3D%3D Repka MX, Savino PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983; 96: 478–83
15. 15. SS Hayreh P Podhajsky MB Zimmerman 1999 Role of nocturnal arterial hypotension in optic nerve head ischemic disorders Ophthalmologica 213 76 96 9885384 10.1159/000027399 1:STN:280:DyaK1M7gsVamtA%3D%3D Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999; 213: 76–96
16. 16. SM Chung CA Gay JA McCrary III 1994 Non-arteritic ischemic optic neuropathy: the impact of tobacco use Ophthalmology 101 779 82 8152775 1:STN:280:DyaK2c3gtlKgtg%3D%3D Chung SM, Gay CA, McCrary III JA. Non-arteritic ischemic optic neuropathy: the impact of tobacco use. Ophthalmology 1994; 101: 779–82
17. 17. SS Hayreh KM Joos PA Podhajsky 1994 Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy Am J Ophthalmol 118 766 80 7977604 1:STN:280:DyaK2M%2FmvVaitA%3D%3D Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 118: 766–80
18. 18. T Reffelmann RA Kloner 2006 Cardiovascular effects of phosphodi-esterase 5 inhibitors Curr Pharm Des 12 3485 94 17017941 10.2174/138161206778343073 1:CAS:528:DC%2BD28XhtVGlt7%2FE Reffelmann T, Kloner RA. Cardiovascular effects of phosphodi-esterase 5 inhibitors. Curr Pharm Des 2006; 12: 3485–94
19. 19. RM Zusman LM Prisant MJ Brown 2000 Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group J Hypertens 18 1865 9 11132612 10.1097/00004872-200018120-00022 1:CAS:528:DC%2BD3MXhtlChtQ%3D%3D Zusman RM, Prisant LM, Brown MJ. Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group. J Hypertens 2000; 18: 1865–9
20. 20. DJ Webb S Freestone MJ Allen 1999 Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist Am J Cardiol 83 21 28C 10.1016/S0002-9149(99)00044-2 Webb DJ, Freestone S, Allen MJ, et al. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999; 83: 21–28C
21. 21. MA Mittleman M Maclure DB Glasser 2005 Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate Am J Cardiol 96 443 6 16054479 10.1016/j.amjcard.2005.03.097 1:CAS:528:DC%2BD2MXmvVWltrk%3D Mittleman MA, Maclure M, Glasser DB. Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate. Am J Cardiol 2005; 96: 443–6
22. 22. Committee on the Assessment of the US Drug Safety System. The future of drug safety: promoting and protecting the health of the public [online]. Available from URL: http://www.iom.edu/CMS/3793/26341/37329.aspx [Accessed 2008 Jan 23]
23. 23. BM Psaty SP Burke 2006 Protecting the health of the public: Institute of Medicine recommendations on drug safety N Engl J Med 355 1753 5 17030843 10.1056/NEJMp068228 1:CAS:528:DC%2BD28XhtFCis7%2FL Psaty BM, Burke SP. Protecting the health of the public: Institute of Medicine recommendations on drug safety. N Engl J Med 2006; 355: 1753–5
24. 24. DS Budnitz DA Pollock KN Weidenback 2006 National surveillance of emergency department visits for outpatient adverse drug events JAMA 296 1858 66 17047216 10.1001/jama.296.15.1858 1:CAS:528:DC%2BD28XhtFWmsL%2FN Budnitz DS, Pollock DA, Weidenback KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858–66
25. 25. FDA news. FDA and VA to share information on the safe use of medical products [online]. Available from URL: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01552.html [Accessed 2007 Apr 12]
26. 26. The Erice Manifesto: for global reform of the safety of medicines in patient care. Drug Saf 2007; 30: 187–90